Indeed, patients with ICI-T1DM had a more robust Tfh cell response than those without IrAEs, with increased CD4+ICOS+PD-1hiCXCR5+ cells compared with controls without autoimmunity (Figure 1B; P < 0.05). This evidence concerns the gene ICOS and type 1 diabetes mellitus.